Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;51(5):2570-2574.
doi: 10.3906/sag-2101-348. Epub 2021 Oct 21.

Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis

Ayla Çulha Oktar  1 , Özlem Selçuk  1 , Cansu Elmas Tunç  1 , Şenol Işıldak  2 , Elif Şanlı  2 , Vuslat Yılmaz  2 , Birgül Baştan Tüzün  1 , Murat Kürtüncü  3 , Ayşe Özlem Çokar  1 , Erdem Tüzün  2
Affiliations
Free article

Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis

Ayla Çulha Oktar et al. Turk J Med Sci. 2021 Oct.
Free article

Abstract

Background: Ganglioside antibodies are identified not only in patients with inflammatory neuropathies but also several central nervous system disorders and paraneoplastic neuropathies. Our aim was to investigate whether ganglioside antibodies are found in autoimmune encephalitis patients and may function as a diagnostic and prognostic biomarker.

Methods: Sera and cerebrospinal fluid (CSF) samples of 33 patients fulfilling the criteria for probable autoimmune encephalitis were collected within the first week of clinical manifestation. None of the patients had evident symptoms and findings of peripheral polyneuropathy. Well-characterized antineuronal and paraneoplastic antibodies were investigated in sera and CSF and antiganglioside (antiGM1, GM2, GM3, GD1a, GD1b, GT1b, and GQ1b) IgG and IgM antibodies were measured in sera using commercial immunoblots.

Results: Twenty-eight of 33 autoimmune encephalitis patients displayed antibodies against neuronal surface or onco-neural antigens with N-methyl-D-aspartate receptor (NMDAR), glutamic acid decarboxylase (GAD) and Hu antibodies being the most prevalent. While no antiganglioside IgG antibodies were found, 4 patients (2 anti-NMDAR+, 1 anti-GAD+ and 1 antibody negative) with autoimmune limbic encephalitis displayed anti-GM1, anti-GM2, anti-GM3 or anti-GQ1b IgM antibodies. There was no apparent association between antiganglioside positivity and clinical and demographic features.

Discussion: Serum ganglioside IgM antibodies may infrequently emerge during the clinical course of autoimmune limbic encephalitis without evident polyneuropathy. Absence of the IgG response suggests that these antibodies might have developed as a hyperacute immune response to neuro-axonal destruction. Nevertheless, potential impact of ganglioside antibodies on axonal degeneration and neuronal loss in limbic encephalitis pends to be further investigated.

Keywords: Ganglioside; antibody; autoimmune encephalitis; autoimmunity; paraneoplastic.

PubMed Disclaimer

References

    1. Wanleenuwat P, Iwanowski P, Kozubski W. Antiganglioside antibodies in neurological diseases. Journal of the Neurological Sciences 2020; 408: 116576. - DOI
    1. Colsch B, Jackson SN, Dutta S, Woods AS. Molecular microscopy of brain gangliosides: illustrating their distribution in hippocampal cell layers. ACS Chemical Neuroscience 2011; 2 (4): 213-222. - DOI
    1. Timarova G, Lisa I, Kukumberg P. Long-term effect of rituximab in a case with late-onset Rasmussen´s encephalitis with anti-ganglioside IgGQ1b and anti-GAD antibodies positivity. Case Report. Neuro Endocrinology Letters 2016; 37 (3): 179-183.
    1. Çoban A, Ulusoy C, Giriş M, Turan S, Türkoğlu R et al. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. The International Journal of Neuroscience 2013; 123 (8): 557-562.
    1. Ding Y, Yu L, Zhou S, Zhang L. Clinical characteristic analysis of seven children with bickerstaff brainstem encephalitis in China. Frontiers in Neurology 2020; 11: 557. - DOI

Supplementary concepts

LinkOut - more resources